More than 50% of pharmaceuticals in current use are chiral compounds. Enantiomers of the
same pharmaceutical have identical physicochemical properties, but may exhibit differences …

In the last decades an increasing number of studies has been published concerning
contamination of aquatic ecosystems with pharmaceuticals. Yet, the distribution of these …

Hospital wastewater represents a significant input of pharmaceuticals into municipal
wastewater. As Moving Bed Biofilm Reactors (MBBRs) appear to remove organic micro …

Present technologies for wastewater treatment do not sufficiently address the increasing
pollution situation of receiving water bodies, especially with the growing use of personal …

This is the first study presenting a multi-residue method allowing for comprehensive analysis
of several chiral pharmacologically active compounds (cPACs) including beta-blockers …

The MBR market continues to experience a massive growth. The best practice in the field is
constantly changing and unique quality requirements and management issues are regularly …

At present, there is a serious concern about the alarming number of recalcitrant
contaminants that can negatively affect biodiversity threatening the ecological status of …

Beta-blockers (BB) are one of the most widely used pharmaceuticals whose presence in
different environmental compartments has already been proven in concentrations of even up …

The degradation of seven compounds which are usually recalcitrant in classical activated
sludge treatment (eg, diclofenac, propranolol, iopromide, iohexol, iomeprol tebuconazole …

Emerging contaminants such as pharmaceuticals, illicit drugs and personal care products
can be released to the environment in untreated wastewater/stormwater mixtures following …